Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature. Issue 1 (January 2016)

• Record Type: Journal Article
• Authors: Vaubel, Rachael A.; Chen, Selby G.; Raleigh, David R.; Link, Michael J.; Chicoine, Michael R.; Barani, Igor; Jenkins, Sarah M.; Aleff, Patrice Abell; Rodriguez, Fausto J.; Burger, Peter C.; Dahiya, Sonika; Perry, Arie; Giannini, Caterina
• Is Part Of: Journal of neuropathology and experimental neurology. Volume 75:Issue 1(2016)
• Publication Date: 2016-01
• Subjects: Anaplastic meningioma -- Meningioma -- Rhabdoid meningioma -- WHO grade; Neurology -- Diseases -- Periodicals; Neurology -- Diseases -- Physiopathology -- Periodicals; 616.8047
• DOI: 10.1093/jnen/nlv006
• Languages: English
• ISSNs: 0022-3069

Abstract

Abstract : The behavior of rhabdoid meningiomas otherwise lacking malignant features remains unknown as most of the originally reported aggressive cases showed anaplastic histologic features independently of rhabdoid phenotype. We studied 44 patients with rhabdoid meningiomas lacking anaplastic features. Median age at diagnosis was 48.6 years (range 10–79). Location was supratentorial in 28 (63.6%), skull base in 15 (34.1%), and spinal in 1 (2.3%). Tumor grade was otherwise World Health Organization grade I (n = 22, 50%) or II (n = 22, 50%). Rhabdoid cells represented <20% of the tumor in 12 cases (27.3%), 20% to 50% in 18 (40.9%), and >50% in 14 (31.8%). Median clinical follow-up, available for 38 patients, was 5.0 years (range 0.17–14.2). Recurrence occurred in 9 patients (5-year recurrence-free survival, 73.7%) with a significantly higher risk in subtotally resected tumors (p = 0.043). Rhabdoid cell percentage was not associated with recurrence. Six patients died (4 of disease, 2 of unclear causes); 5-year overall survival was 86.7%, a mortality in excess of that expected in grade I–II meningiomas but much lower than originally reported. Review of 50 similar previously reported cases confirmed our findings. We suggest that rhabdoid meningiomas be graded analogously to nonrhabdoid tumors, with caution that some may still behave aggressively and close follow-up is recommended.